TOPIFRAM LABORATORIES, INC. – Trademark Portfolio
Entity Type: 03
TOPIFRAM LABORATORIES, INC. holds 15 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 3 (Cosmetics & Cleaning) — 13 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 5 trademarks are registered. Notable registered marks include EVENTONE, TOPIFRAM, and AGE SPOT FORMULA. The owner is based in ENGLEWOOD CLIFFS, NJ.
140 SYLVAN AVENUE
ENGLEWOOD CLIFFS, NJ 07632
Showing of trademarks Trademarks
Trademark Classifications
TOPIFRAM LABORATORIES, INC.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does TOPIFRAM LABORATORIES, INC. have?
TOPIFRAM LABORATORIES, INC. has 15 U.S. trademarks filed with the USPTO. Of these, 5 registered, 2 abandoned, 8 cancelled.
What trademark classes does TOPIFRAM LABORATORIES, INC. file in?
TOPIFRAM LABORATORIES, INC. files trademarks across 2 Nice Classification classes. The most active classes are Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals). Class 3 covers bleaching preparations and other substances for laundry use; cleaning, polishing, scouring.
What are TOPIFRAM LABORATORIES, INC.'s most well-known trademarks?
TOPIFRAM LABORATORIES, INC.'s registered trademark portfolio includes well-known marks such as EVENTONE, TOPIFRAM, and AGE SPOT FORMULA. These are among 5 currently registered trademarks in the portfolio.
What is TOPIFRAM LABORATORIES, INC.'s trademark registration success rate?
TOPIFRAM LABORATORIES, INC. has a 33% trademark registration rate, with 5 out of 15 resolved applications resulting in successful registration. Currently, 0 applications are pending review.